Results 131 to 140 of about 24,961 (206)

Secondary Strongyloides stercoralis prophylaxis in patients with human T-cell lymphotropic virus type 1 infection: report of two cases

, 2009
SummarySecondary ivermectin prophylaxis for strongyloidiasis in two patients with human T-cell lymphotropic virus type 1 (HTLV-1)-associated malignancies and fully treated complicated strongyloidiasis is described.
Peters, Laurenna, McCarthy, Anne E., Faught, Carolyn   +2 more
core   +1 more source

Characterisation of llama antibody fragments able to act as HIV-1 entry inhibitors [PDF]

, 2009
Human immunodeficiency virus type 1 (HIV-1) entry into cells is mediated by the functional envelope spike, which consists of trimers of gp120 bound to gp41.
Forsman, A M M, Forsman, A.M.M.
core  

Human T Cell Lymphotropic Virus Type II and Human Immunodeficiency Virus Type 1 Disease Progression [PDF]

The Journal of Infectious Diseases, 1997
Lee H. Harrison, Mauro Schechter
openaire   +2 more sources

Mother-to-child Transmission of Human T-cell Lymphotropic Virus Type 1

Pediatric Infectious Disease Journal, 2013
Hiroyuki, Moriuchi, Hideaki, Masuzaki, Hiroshi, Doi, Shigeru, Katamine   +3 more
openaire   +2 more sources

[Human T-cell lymphotropic virus type 1(HTLV-1)-associated myelopathy].

Revista da Sociedade Brasileira de Medicina Tropical, 2002
HTLV-1-associated myelopathy (HAM), also known as tropical spastic paraparesis (TSP), is a chronic progressive demyelinating disease that affects the spinal cord and white matter of the central nervous system. The lifetime incidence of HAM in HTLV-1 carriers is estimated to be less than 5%.
João Gabriel Ramos, Ribas, Gustavo Correa Netto, Melo   +1 more
openaire   +1 more source

Can thymic epithelial cells be infected by human T-lymphotropic virus type 1?

, 2012
The human T-lymphotropic virus type-1 (HTLV-1) is the cause of adult T cell leukaemias/lymphoma. Because thymic epithelial cells (TEC) express recently defined receptors for the virus, it seemed conceivable that these cells might be a target for HTLV-1 ...
Moreira-Ramos, Klaysa, Castro, Flávia, Linhares-Lacerda, Leandra, Savino, Wilson   +3 more
core   +2 more sources

Human T-cell lymphotropic virus type 1 transmission dynamics in rural villages in the Democratic Republic of the Congo with high nonhuman primate exposure. [PDF]

PLoS Negl Trop Dis, 2021
Halbrook M, Gadoth A, Shankar A, Zheng H, Campbell EM, Hoff NA, Muyembe JJ, Wemakoy EO, Rimoin AW, Switzer WM.   +9 more
europepmc   +1 more source

Molecular detection of human T cell lymphotropic virus type 1 in pregnant women from Maranhão state, Brazil. [PDF]

Braz J Microbiol, 2020
de Fátima Castro Mendes M, de Ribamar Oliveira Lima J, de Oliveira de Melo B, de Maria Fernandes da Silva Pinto C, Maia HS, Ferro TAF, Monteiro SG, Stancioli EFB, Bomfim MRQ.   +8 more
europepmc   +1 more source

Dolutegravir Reduces Human T-Cell Lymphotropic Virus Type 1 Proviral Load and Improves Neurological Outcomes in a Phase 2 Controlled Trial. [PDF]

Clin Infect Dis
Brites C, Montaño-Castellon I, Arriaga MB, Marconi C, Mayoral R, Luz E, Figueredo CA, Fiuza BSD, Netto EM.   +8 more
europepmc   +1 more source

Chronic course of human T-cell lymphotropic virus type-1-associated bronchioloalveolar disorder diagnosed using transbronchial lung cryobiopsy. [PDF]

Respir Med Case Rep
Hiromi A, Yamakawa H, Ohta H, Kusano K, Adachi A, Yamaguchi Y, Matsushima H.   +6 more
europepmc   +1 more source